These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9014433)

  • 1. [Brain tumor and parkinsonism].
    Kondo T
    Nihon Rinsho; 1997 Jan; 55(1):118-22. PubMed ID: 9014433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subacute worsening of rigidity in a patient with Parkinson disease].
    Bekkelund SI; Lilleng H; Arntzen KA
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2065-6. PubMed ID: 18853522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Motor symptoms in Parkinson disease].
    Larsen JP; Beiske AG; Bekkelund SI; Dietrichs E; Tysnes OB; Vilming ST; Aasly JO
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2068-71. PubMed ID: 18846123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa-responsive parkinsonism associated with hydrocephalus.
    Kim MJ; Chung SJ; Sung YH; Lee MC; Im JH
    Mov Disord; 2006 Aug; 21(8):1279-81. PubMed ID: 16639728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["Red flags": when to be alerted and how to explore?].
    Tison F
    Rev Neurol (Paris); 2010 Oct; 166(10):775-8. PubMed ID: 20817230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinsonism associated with neurocysticercosis.
    Sá DS; Teive HA; Troiano AR; Werneck LC
    Parkinsonism Relat Disord; 2005 Jan; 11(1):69-72. PubMed ID: 15619466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
    Kondo T
    J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular parkinsonism: what makes it different?
    Gupta D; Kuruvilla A
    Postgrad Med J; 2011 Dec; 87(1034):829-36. PubMed ID: 22121251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration.
    Steiger MJ; Pires M; Scaravilli F; Quinn NP; Marsden CD
    Mov Disord; 1992; 7(1):71-7. PubMed ID: 1557069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions.
    Wilcox RA; Churchyard A; Dahl HH; Hutchison WM; Kirby DM; Thyagarajan D
    Mov Disord; 2007 May; 22(7):1020-3. PubMed ID: 17357142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary spastic paraplegia associated with dopa-responsive parkinsonism.
    Micheli F; Cersósimo MG; Zúñiga Ramírez C
    Mov Disord; 2006 May; 21(5):716-7. PubMed ID: 16463348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-motor symptoms may herald Parkinson's disease.
    Khoo TK; Burn DJ
    Practitioner; 2009 Sep; 253(1721):19-24, 2. PubMed ID: 19873855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parkinsonism in Alzheimer's disease].
    Odawara T; Iseki E; Kosaka K
    Nihon Rinsho; 1997 Jan; 55(1):149-52. PubMed ID: 9014440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor fluctuations in Parkinson's disease.
    Weiner WJ
    Rev Neurol Dis; 2006; 3(3):101-8. PubMed ID: 17047575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Parkinson's disease.
    Eadie MJ
    Aust Fam Physician; 1995 Sep; 24(9):1685-7, 1690-2. PubMed ID: 7487655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa and the progression of Parkinson's disease.
    Walton-Hadlock JL
    N Engl J Med; 2005 Mar; 352(13):1386; author reply 1386. PubMed ID: 15800240
    [No Abstract]   [Full Text] [Related]  

  • 17. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced Parkinson's disease.
    Diamond A; Jankovic J
    Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate Parkinson's disease. Strategies for maximizing treatment.
    Silverstein PM
    Postgrad Med; 1996 Jan; 99(1):52-4, 61-3, 67-8, passim. PubMed ID: 8539210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
    Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
    Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.